Wednesday 9/30 Insider Buying Report: DEI, GLSI

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

At Douglas Emmett, a filing with the SEC revealed that on Monday, Chief Exec Officer, President Jordan L.

Kaplan purchased 39,300 shares of DEI, for a cost of $25.38 each, for a total investment of $997,382.

So far Kaplan is in the green, up about 1.8% on their buy based on today's trading high of $25.84.

Douglas Emmett is trading up about 3.1% on the day Wednesday.

This buy marks the first one filed by Kaplan in the past twelve months.

And on Tuesday, Director Kenneth Hallock bought $429,996 worth of Greenwich Lifesciences, buying 74,782 shares at a cost of $5.75 each.

Greenwich Lifesciences is trading up about 2% on the day Wednesday.

Investors have the opportunity to buy GLSI at a price even lower than Hallock did, with shares changing hands as low as $4.60 at last check today which is 20.0% under Hallock's purchase price.